Background
Since the beginning of the COVID-19 pandemic, empirical antibiotics
prescription has increased globally in patients with COVID-19 for
suspected or confirmed bacterial infection. Hence, concerns have been
raised about potential rise in antibiotic resistance that will create
further challenges for antimicrobial stewardship.